Baxter Trading GmbH
Records under this name other than patents Baxter Trading GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,033,590 | Factor IX/factor IXa activating antibodies and antibody derivatives Formerly held Term ended Term ended Dec 20, 2021 · From the USPTO record | Term ended | Term ended Dec 20, 2021 | From the USPTO record |
| US 6,958,322 | Factor X analog with an improved ability to be activated Formerly held Term ended Term ended Sep 3, 2021 · From the USPTO record | Term ended | Term ended Sep 3, 2021 | From the USPTO record |
| US 6,974,792 | Alpha 1-Antitrypsin Preparation as Well as a Method for Producing the Same Formerly held Term ended Term ended Jun 10, 2021 · Medium confidence | Term ended | Term ended Jun 10, 2021 | Medium confidence |
| US 8,709,492 | Process for producing a plasma protein-containing medicament with reduced concentration of citrate and metals Formerly held Term ended Term ended May 4, 2021 · Medium confidence | Term ended | Term ended May 4, 2021 | Medium confidence |
| US 7,241,603 | Method for Producing a Preparation Based on Fibrinogen and Fibronectin as Well as Protein Compositions Obtainable According to This Method Formerly held Term ended Term ended Dec 1, 2020 · Medium confidence | Term ended | Term ended Dec 1, 2020 | Medium confidence |
| US 6,506,365 | Fibrin/fibrinogen binding conjugate Formerly held Term ended Term ended Sep 25, 2020 · From the USPTO record | Term ended | Term ended Sep 25, 2020 | From the USPTO record |
| US 6,713,453 | Fibrin/Fibrinogen-Binding Conjugate Formerly held Term ended Term ended Sep 25, 2020 · Medium confidence | Term ended | Term ended Sep 25, 2020 | Medium confidence |
| US 7,091,325 | Fibrin/Fibrinogen-Binding Conjugate Formerly held Term ended Ended no later than Sep 25, 2020 · Low confidence | Term ended | Ended no later than Sep 25, 2020 | Low confidence |
| US 7,279,161 | Factor IX/Factor Ixa Activating Antibodies and Antibody Derivatives Formerly held Term ended Term ended Sep 14, 2020 · Medium confidence | Term ended | Term ended Sep 14, 2020 | Medium confidence |
| US 9,441,203 | Medium for the Protein-Free and Serum-Free Cultivation of Cells Formerly held Lapsed on the fee record Ended Sep 13, 2020 · Low confidence | Lapsed on the fee record | Ended Sep 13, 2020 | Low confidence |